sözaltı news Health
Health
EN AZ
This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

marketwatch.com 22.09.2026 17:46 37 views
Viking Therapeutics is developing VK2735, a GLP-1/GIP drug that could compete with Eli Lilly’s Zepbound. Its stock is soaring.
Similar stories 1 outlet
Optimising a digitally delivered behavioural weight loss programme: a factorial cluster randomised controlled trial nature.com 19.09.2026
Related stories
A&E warning system to flag sick children deteriorating quickly
A&E warning system to flag sick children deteriorating quickly
bbc.co.uk · 02.11
 Ciara Mageean, Irish 1500-Meter Champion and Olympian, Dies at 34
Ciara Mageean, Irish 1500-Meter Champion and Olympian, Dies at 34
runnersworld.com · 01.11
 'I felt ostracised due to cleft lip'
'I felt ostracised due to cleft lip'
bbc.co.uk · 01.11
 Cleft lip filler 'boosts confidence' - but expert warns of exploitation risk
Cleft lip filler 'boosts confidence' - but expert warns of exploitation risk
bbc.co.uk · 01.11
 These Are the World’s Fastest Marathoners
These Are the World’s Fastest Marathoners
runnersworld.com · 01.11
 Zouhair Talbi Runs a Bold Race, Leading 3 Americans Into the Top 10 at the NYC Marathon
Zouhair Talbi Runs a Bold Race, Leading 3 Americans Into the Top 10 at the NYC Marathon
runnersworld.com · 01.11